Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Postoperative cystoid macular oedema in a patient on fingolimod.
Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis.
Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis.
Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis.
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines Neurodegeneration.
Visualization of acute focal lesions in rats with experimental autoimmune encephalomyelitis by magnetic nanoparticles, comparing different MRI sequences including phase imaging.
Structural correlates of subjective and objective memory performance in multiple sclerosis.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
Cambridge Healthtech Institute's Third Annual Anti-inflammatories: small Molecules Meeting, April 17(th) - 18(th) 2012, San Diego, USA.
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
Abstracts.
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
The influence of glutamatergic receptor antagonists on biochemical and ultrastructural changes in myelin membranes of rats subjected to experimental autoimmune encephalomyelitis.
Systematic Review and meta-analysis of the Efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in Animal Models of Stroke.
[The effect of genetic factors on the phenotypic expression of multiple sclerosis.]
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Author response.
Relationship between vitamin D deficiency and visually evoked potentials in multiple sclerosis.
Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Pages
« first
‹ previous
…
466
467
468
469
470
471
472
473
474
…
next ›
last »